Articular cartilage injury
Drug research and approvals for articular cartilage injury: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 22, 2026, 10 studies of articular cartilage injury are recruiting on ClinicalTrials.gov, and Health Canada has authorized 5 drug trials for it since 2013.
- Recruiting worldwide: 10
- Trials authorized in Canada: 5
- FDA orphan approvals: 0
- EU medicines: 0
Newest posted first, of 10 recruiting on ClinicalTrials.gov ↗
- Knee Cartilage Repair RegistryNCT07786207 · Not reported · Smith & Nephew, Inc. · starts Sep 23, 2026
- Development of Computational Models to Predict the Short-, Medium- and Long-term Cartilage Degeneration and Pain for…NCT07134244 · Not reported · Aalborg University · starts Sep 26, 2024
- Tissue Engineered Cartilage to Repairing Articular Cartilage DefectsNCT07094100 · Not applicable · The First Affiliated Hospital of Xinxiang Medical College · starts Apr 20, 2026
- Impact of Bone-Marrow Aspirate Injections in Knee ArthroscopyNCT06893302 · Not applicable · Hospital for Special Surgery, New York · starts Feb 3, 2026
- Developing Allogeneic Musculoskeletal TherapiesNCT06167928 · Not reported · Keele University · starts Oct 8, 2018
- Effect of Platelet-rich Plasma (PRP) Injection on Knee OsteoarthritisNCT06082531 · Not applicable · Xijing Hospital · starts Sep 1, 2023
- Gait Rehabilitation to Treat FastOANCT05848622 · Not applicable · University of North Carolina, Chapel Hill · starts Jun 13, 2023
- AMIC Compared With Microfracture for Focal Articular Cartilage Damage of the HipNCT05402072 · Phase 1 · McMaster University · starts Mar 13, 2023
- Hydrolyzed Collagen Formulation vs Placebo in Knee OsteoarthritisNCT04998188 · Not applicable · Istituto Ortopedico Rizzoli · starts Feb 16, 2022
Newest first; search them all in Canada trials
| Jul 15, 2016 | A randomized comparison of neocart to microfracture for the repair of articular cartilage injuries in the kneeNeocart | Histogenics Corp | Ongoing |
| May 24, 2016 | Pharmacologic reversal of ventricular remodeling in childhood cancer survivors at risk for heart failure (prevent-hf): a phase 2b randomized placebo-controlled…Carvedilol | Childrens Oncology Group | Closed |
| Mar 9, 2016 | A phase 1/1b, open-label, multicenter, repeat-dose, dose-selection study of CPI-444 as single agent and in combination with atezolizumab in patients with…Ciforadenant (CPI-444) / Atezolizumab | Corvus Pharmaceuticals | Closed |
| Nov 9, 2015 | Efficacy and safety of rivaroxaban prophylaxis compared with placebo in ambulatory cancer patients initiating systemic cancer therapy and at high risk for…Xarelto (rivaroxaban, bay 59-7939) | Johnson & Johnson | Closed |
| Nov 17, 2014 | Impact of cleansing with chlorhexidine gluconate (CHG) on reducing central line associated bloodstream infection (CLABSI) and acquisition of multi-drug…Chlorhexidine gluconate | Childrens Oncology Group | Closed |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA